Canlyniadau Chwilio - David Liebowitz

Estimating time since influenza virus exposure using single-cell proteomic data gan Klodiana Rizzo Nervo, Neda Hajiakhoond Bidoki, Han Chen, Zainab Rahil, Zach Bjornson, Kenneth Kim, Bonnie Bock, Melton Affrime, Logan Bauerle, Pham Bao Tran Huynh, David Liebowitz, Sean Tucker, Pier Federico Gherardini, Garry P. Nolan, Nima Aghaeepour, David R. McIlwain

Cael y testun llawn

Safety, tolerability, and immunogenicity of a DNA-based vaccine (INO-4700) against Middle East respiratory syndrome coronavirus: phase 2a study in healthy volunteers gan Joseph T. Agnes, Sarah A. Marcus, Sahem S. Al-Ghraibeh, Suleimman Ahmad Al-Sweedan, Josphat Kosgei, Bernhards Ogutu, ShuPing Yang, Kathleen A. Walker, Bonaventure Orizu, Kate E. Broderick, Jean Boyer, Stephanie Ramos, Matthew P. Morrow, Kimberly Kraynyak, Albert J. Sylvester, Elisabeth Gillespie, David Liebowitz, Laurent M. Humeau

Cael y testun llawn

Safety, tolerability, and immunogenicity of INO-4500, a synthetic DNA-based vaccine against Lassa virus, in a phase 1b clinical trial in healthy Ghanaian adults gan Kwadwo Ansah Koram, Kathleen A. Walker, Bonaventure Orizu, Idania Marrero, Jean Boyer, ShuPing Yang, Kate E. Broderick, Kwadwo Asamoah Kusi, Eric Kyei-Baafour, Ebenezer Addo Ofori, Abigail Pobee, Susan Adu-Amankwah, Mary Amoakoh-Coleman, Hannah Brown Amoakoh, Hannah Brown Amoakoh, Benjamin Abuaku, Edem Badji, Michael Ntiri, Lydia Quaye, Matthew P. Morrow, Albert J. Sylvester, Emma L. Reuschel, Elisabeth Gillespie, David Liebowitz, Laurent M. Humeau

Cael y testun llawn